Board of Directors
The PMC board of directors is dedicated to supporting the Coalition’s work to promote the understanding and adoption of personalized medicine concepts, services, and products.
Board Vice Chair
Sarah Hersey, M.S., M.B.A., R.A.C.
Vice President, Precision Medicine, Bristol Myers Squibb
Okan Ekinci, MD, MBA
Global Head of Digital Technology and Chief Medical Information Officer, Roche Information Solutions
Megan P. Hall, PhD
Vice President of Medical & Corporate Affairs and Distinguished Scientist, GRAIL, Inc.
Kristin Ciriello Pothier
Principal, US and Americas Region Life Sciences Sector Leader and Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences KPMG
Cecilia Schott, Pharm.D.
Vice President, Head of Precision Medicine Portfolio Planning, GlaxoSmithKline
Anthony Sireci, MD, MSc
Senior Vice President of Clinical Biomarkers, Laboratories and Diagnostics, Eli Lilly and Company
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center
